Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 17/20 | 0.57 |
| ▸ | CNR1 | P21554 | 4/20 | 0.57 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.45 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.44 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.44 |
| ▸ | ITGB7 | P26010 | 1/20 | 0.44 |
| ▸ | AVPR1B | P47901 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7216957 | 0.89 | CNR2 (0.69) | CNR2CNR1HSP90AA1ITGB1ITGA4 | |
| SCHEMBL7218554 | 0.89 | CNR2 (0.55) | CNR2CNR1HSP90AA1ITGB1ITGA4 | |
| SCHEMBL7222587 | 0.87 | CNR2 (0.54) | CNR2CNR1HSP90AA1ITGB1ITGA4 | |
| SCHEMBL7218675 | 0.83 | CNR2 (0.65) | CNR2CNR1ITGB1ITGA4ITGB7 | |
| SCHEMBL7223428 | 0.83 | CNR2 (0.67) | CNR2CNR1ITGB1ITGA4ITGB7 | |
| SCHEMBL7218530 | 0.82 | CNR2 (0.62) | CNR2CNR1 | |
| SCHEMBL7218743 | 0.81 | CNR2 (0.70) | CNR2CNR1ITGB1ITGA4ITGB7 | |
| SCHEMBL7224319 | 0.79 | CNR2 (0.71) | CNR2CNR1ITGB1ITGA4ITGB7 | |
| SCHEMBL7641363 | 0.79 | CNR2 (0.69) | CNR2CNR1ITGB1ITGA4ITGB7 | |
| SCHEMBL7222304 | 0.77 | CNR2 (0.61) | CNR2CNR1ITGB1ITGA4ITGB7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6653304-B2 | Antiarthritic agents; skin disorders; anticarcinogenic agents | BRISTOL-MYERS SQUIBB CO. | 2003-11-25 | — | — | US | disclosed |